Century Therapeutics Stock Price History
IPSC Stock | USD 0.77 0.02 2.67% |
If you're considering investing in Century Stock, it is important to understand the factors that can impact its price. As of today, the current price of Century Therapeutics stands at 0.77, as last reported on the 16th of February 2025, with the highest price reaching 0.81 and the lowest price hitting 0.74 during the day. Century Therapeutics secures Sharpe Ratio (or Efficiency) of -0.14, which signifies that the company had a -0.14 % return per unit of risk over the last 3 months. Century Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Century Therapeutics' Mean Deviation of 3.45, standard deviation of 4.7, and Risk Adjusted Performance of (0.12) to double-check the risk estimate we provide.
The current year's Stock Based Compensation is expected to grow to about 17.7 M, whereas Total Stockholder Equity is forecasted to decline to about 192.9 M. . At present, Century Therapeutics' Price To Book Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 1.01, whereas Price To Sales Ratio is forecasted to decline to 58.04. Century Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Century |
Sharpe Ratio = -0.1437
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | IPSC |
Estimated Market Risk
4.76 actual daily | 42 58% of assets are more volatile |
Expected Return
-0.68 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Century Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Century Therapeutics by adding Century Therapeutics to a well-diversified portfolio.
Price Book 0.3365 | Enterprise Value Ebitda 0.0752 | Price Sales 24.5361 | Shares Float 34.1 M | Wall Street Target Price 8.5 |
Century Therapeutics Stock Price History Chart
There are several ways to analyze Century Stock price data. The simplest method is using a basic Century candlestick price chart, which shows Century Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 29, 2024 | 1.72 |
Lowest Price | February 10, 2025 | 0.72 |
Century Therapeutics February 16, 2025 Stock Price Synopsis
Various analyses of Century Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Century Stock. It can be used to describe the percentage change in the price of Century Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Century Stock.Century Therapeutics Price Action Indicator | 0.01 | |
Century Therapeutics Price Daily Balance Of Power | 0.29 | |
Century Therapeutics Price Rate Of Daily Change | 1.03 |
Century Therapeutics February 16, 2025 Stock Price Analysis
Century Stock Price History Data
The price series of Century Therapeutics for the period between Mon, Nov 18, 2024 and Sun, Feb 16, 2025 has a statistical range of 1.0 with a coefficient of variation of 23.79. Under current investment horizon, the daily prices are spread out with arithmetic mean of 1.1. The median price for the last 90 days is 1.05.Open | High | Low | Close | Volume | ||
02/16/2025 | 0.77 | 0.81 | 0.74 | 0.77 | ||
02/14/2025 | 0.77 | 0.81 | 0.74 | 0.77 | 514,680 | |
02/13/2025 | 0.75 | 0.78 | 0.72 | 0.75 | 308,573 | |
02/12/2025 | 0.71 | 0.76 | 0.71 | 0.75 | 159,056 | |
02/11/2025 | 0.71 | 0.74 | 0.68 | 0.73 | 286,914 | |
02/10/2025 | 0.74 | 0.74 | 0.71 | 0.72 | 381,103 | |
02/07/2025 | 0.76 | 0.78 | 0.72 | 0.73 | 516,777 | |
02/06/2025 | 0.79 | 0.80 | 0.75 | 0.76 | 498,396 | |
02/05/2025 | 0.79 | 0.81 | 0.78 | 0.80 | 185,313 | |
02/04/2025 | 0.80 | 0.84 | 0.76 | 0.79 | 354,243 | |
02/03/2025 | 0.81 | 0.86 | 0.75 | 0.78 | 409,109 | |
01/31/2025 | 0.85 | 0.89 | 0.81 | 0.82 | 531,060 | |
01/30/2025 | 0.82 | 0.89 | 0.78 | 0.85 | 997,825 | |
01/29/2025 | 0.84 | 0.86 | 0.82 | 0.82 | 635,815 | |
01/28/2025 | 0.87 | 0.88 | 0.83 | 0.85 | 584,108 | |
01/27/2025 | 0.91 | 0.94 | 0.86 | 0.87 | 575,180 | |
01/24/2025 | 0.91 | 0.93 | 0.87 | 0.90 | 535,630 | |
01/23/2025 | 0.90 | 0.95 | 0.86 | 0.91 | 701,387 | |
01/22/2025 | 0.93 | 0.94 | 0.88 | 0.89 | 292,739 | |
01/21/2025 | 0.93 | 0.94 | 0.89 | 0.90 | 448,630 | |
01/17/2025 | 0.93 | 0.95 | 0.89 | 0.91 | 373,338 | |
01/16/2025 | 0.93 | 0.95 | 0.87 | 0.91 | 412,115 | |
01/15/2025 | 0.95 | 1.00 | 0.90 | 0.94 | 514,161 | |
01/14/2025 | 1.01 | 1.01 | 0.91 | 0.94 | 390,194 | |
01/13/2025 | 0.99 | 1.01 | 0.94 | 0.97 | 462,296 | |
01/10/2025 | 1.07 | 1.07 | 0.98 | 0.99 | 695,580 | |
01/08/2025 | 1.18 | 1.19 | 1.04 | 1.07 | 1,266,461 | |
01/07/2025 | 1.05 | 1.17 | 1.04 | 1.06 | 745,288 | |
01/06/2025 | 1.11 | 1.16 | 1.05 | 1.05 | 333,480 | |
01/03/2025 | 1.04 | 1.14 | 1.04 | 1.11 | 366,862 | |
01/02/2025 | 1.02 | 1.09 | 1.01 | 1.04 | 321,559 | |
12/31/2024 | 1.04 | 1.05 | 0.98 | 1.01 | 374,925 | |
12/30/2024 | 1.05 | 1.05 | 1.00 | 1.00 | 328,921 | |
12/27/2024 | 1.08 | 1.11 | 1.02 | 1.04 | 337,051 | |
12/26/2024 | 1.02 | 1.09 | 0.98 | 1.08 | 367,582 | |
12/24/2024 | 1.02 | 1.03 | 0.95 | 1.02 | 516,025 | |
12/23/2024 | 1.11 | 1.12 | 1.01 | 1.02 | 602,559 | |
12/20/2024 | 1.05 | 1.12 | 1.05 | 1.10 | 1,021,526 | |
12/19/2024 | 1.05 | 1.11 | 0.98 | 1.05 | 829,294 | |
12/18/2024 | 1.17 | 1.17 | 1.03 | 1.05 | 987,422 | |
12/17/2024 | 1.17 | 1.18 | 1.13 | 1.17 | 538,799 | |
12/16/2024 | 1.16 | 1.25 | 1.13 | 1.17 | 1,066,102 | |
12/13/2024 | 1.25 | 1.26 | 1.18 | 1.22 | 953,106 | |
12/12/2024 | 1.37 | 1.38 | 1.24 | 1.25 | 1,017,443 | |
12/11/2024 | 1.40 | 1.43 | 1.33 | 1.35 | 788,208 | |
12/10/2024 | 1.51 | 1.62 | 1.36 | 1.41 | 993,424 | |
12/09/2024 | 1.58 | 1.74 | 1.47 | 1.47 | 1,232,536 | |
12/06/2024 | 1.44 | 1.58 | 1.43 | 1.52 | 544,864 | |
12/05/2024 | 1.41 | 1.48 | 1.40 | 1.43 | 428,604 | |
12/04/2024 | 1.55 | 1.59 | 1.43 | 1.44 | 1,006,490 | |
12/03/2024 | 1.69 | 1.69 | 1.52 | 1.55 | 552,562 | |
12/02/2024 | 1.73 | 1.83 | 1.63 | 1.68 | 690,444 | |
11/29/2024 | 1.65 | 1.75 | 1.62 | 1.72 | 662,603 | |
11/27/2024 | 1.36 | 1.63 | 1.36 | 1.63 | 1,264,844 | |
11/26/2024 | 1.34 | 1.38 | 1.30 | 1.35 | 1,055,221 | |
11/25/2024 | 1.22 | 1.44 | 1.20 | 1.30 | 1,119,866 | |
11/22/2024 | 1.22 | 1.27 | 1.20 | 1.21 | 529,973 | |
11/21/2024 | 1.28 | 1.28 | 1.20 | 1.24 | 325,950 | |
11/20/2024 | 1.26 | 1.29 | 1.22 | 1.26 | 424,256 | |
11/19/2024 | 1.21 | 1.28 | 1.21 | 1.28 | 444,187 | |
11/18/2024 | 1.23 | 1.29 | 1.21 | 1.25 | 428,873 |
About Century Therapeutics Stock history
Century Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Century is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Century Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Century Therapeutics stock prices may prove useful in developing a viable investing in Century Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 68.2 M | 62 M | |
Net Loss | -150.6 M | -158.1 M |
Century Therapeutics Quarterly Net Working Capital |
|
Century Therapeutics Stock Technical Analysis
Century Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
All Next | Launch Module |
Century Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Century Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Century Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Century to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.12) | |||
Jensen Alpha | (0.85) | |||
Total Risk Alpha | (0.86) | |||
Treynor Ratio | (0.78) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Century Stock analysis
When running Century Therapeutics' price analysis, check to measure Century Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Century Therapeutics is operating at the current time. Most of Century Therapeutics' value examination focuses on studying past and present price action to predict the probability of Century Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Century Therapeutics' price. Additionally, you may evaluate how the addition of Century Therapeutics to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Commodity Directory Find actively traded commodities issued by global exchanges |